<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="173847">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00832767</url>
  </required_header>
  <id_info>
    <org_study_id>AS08012</org_study_id>
    <nct_id>NCT00832767</nct_id>
  </id_info>
  <brief_title>SILS™ Port Laparoscopic Cholecystectomy Post Market Study</brief_title>
  <official_title>Prospective Randomized Controlled Trial of Traditional Laparoscopic Cholecystectomy Versus SILS™ Port Laparoscopic Cholecystectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic - MITG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic - MITG</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this trial are:

        1. to assess the feasibility and safety of performing SILS™ Port Laparoscopic
           Cholecystectomy

        2. monitor and compare the outcomes of SILS™ Port Laparoscopic Cholecystectomy versus 4PLC
           to objectively document the scientific merit and the perceived advantages of SILS™ Port
           Laparoscopic Cholecystectomy.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2009</start_date>
  <completion_date type="Anticipated">August 2012</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility and safety of SILS™ port cholecystectomy versus 4PLC as indicated by intraoperative and postoperative adverse events.</measure>
    <time_frame>Ten time points out to one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>Seven time points</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life/ time to return to normal activity</measure>
    <time_frame>Six time points</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cosmesis</measure>
    <time_frame>Five time points</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Gallbladder Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SILS™ Port Laparoscopic Cholecystectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Four Port Laparoscopic Cholecystectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>SILS™ port laparoscopic cholecystectomy</intervention_name>
    <description>This interventional arm will have a single incision laparoscopic cholecystectomy procedure.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Four Port Laparoscopic Cholecystectomy</intervention_name>
    <description>This interventional arm will have a traditional four port laparoscopic cholecystectomy procedure.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Between 18 and 85 years old.

          -  Patient has a diagnosis of biliary colic with documented gallstones or polyps by
             imaging or Biliary dyskinesia with documented EF &lt; 30%.

          -  Body Mass Index (BMI) &lt; 45 kg/m2.

        Exclusion Criteria:

          -  Any female patient, who is pregnant, suspected pregnant, or nursing.

          -  Any patient with acute calculus or acalculous cholecystitis.

          -  Any patient who has had an upper midline or right sub costal incision.

          -  Any patient with pre-operative indication for a cholangiogram.

          -  Any patient with ASA &gt; 3 with normal liver function.

          -  Any patient who is undergoing Peritoneal Dialysis (PD).

          -  Any patient who has an unrepaired umbilical hernia or has had prior umbilical hernia
             repair.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey Marks, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Case Medical Center University Hospitals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Yale New Haven Medical Center</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tampa General Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Shore - Long Island Jewish Health System</name>
      <address>
        <city>Lake Success</city>
        <state>New York</state>
        <zip>11042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Francis Hospital</name>
      <address>
        <city>Roslyn</city>
        <state>New York</state>
        <zip>11576</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UT Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390-8819</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Catholic University of Sacred Heart</name>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Imperial College, England, St. Mary's Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <lastchanged_date>July 31, 2012</lastchanged_date>
  <firstreceived_date>January 29, 2009</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Laparoscopic Cholecystectomy</keyword>
  <keyword>Single Incision Laparoscopic Surgery</keyword>
  <keyword>Surgical Procedures, Minimally Invasive</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Gallbladder Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
